BuzzSparks.org

TetraLogic Pharmaceuticals


TetraLogic Pharmaceuticals is a privately held biopharmaceutical company that discovers and develops small molecule drugs that modulate programmed cell death pathways to treat debilitating diseases and conditions. The company’s Smac Mimetics...

Homepage:
Total money raised: $71M

19355 343 Phoenixville Pike

Malvern
Malvern
USA PA

Phone: 610.889.9900

John M. Gill Founder, President, CEO
Past
Larry Lasky Instrumental in the Founding
Jack W. Lasersohn Board

December, 2012

TetraLogic Pharmaceuticals raised $5M in debt_round round

SEC    sec.gov

May, 2011

TetraLogic Pharmaceuticals raised $6M in a Series C round from Nextech Venture

TetraLogic Closes $6 Million Series C-1 Investment with Nextech Invest Ltd    streetinsider.com

January, 2011

TetraLogic Pharmaceuticals raised $23M in a Series C round

TetraLogic Pulls Down $23M Series C Tranche For Cancer Trials    fis.dowjones.com

September, 2010

TetraLogic Pharmaceuticals raised $5M in a Series C round from Pfizer Venture Investments

TetraLogic Pharma Boosts Series C To $37M With Pfizer Ventures Capital    fis.dowjones.com

August, 2010

TetraLogic Pharmaceuticals raised $32M in a Series C round from Clarus Ventures, Hatteras Venture Partners, Amgen, HealthCare Ventures, Latterell Venture Partners, Novitas Capital, Quaker BioVentures, and The Vertical Group

TetraLogic nabs $32M round for lead cancer therapy Read more: TetraLogic nabs $32M round for lead cancer therapy    fiercebiotech.com